The Two-Period Crossover Design in Medical Research
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The crossover design has enjoyed popularity with many clinical researchers, but has been criticized by biostatisticians. The central problem is the inability to derive an unbiased estimate of the treatment effect when differences occur because of the different sequences in which treatments are applied. This problem can be traced to a deficiency of the logic of the crossover arrangement itself. Factors that can invalidate the findings of a crossover trial include nonuniform pharmacologic and psychologic carry-over effects, failure to return patients to their baseline state before the crossover, nonuniform changes in the patients over time, and the use of time-dependent response measures. When these problems can be anticipated, a parallel-groups design should be used instead of a crossover trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The advantage of the crossover design used in this study is the increase in power of within-participant comparisons, and thus its requirement for fewer participants.”
From A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial (2010) · cites this paper as [26]
In the citing paper
“The design is fitted for stable chronic diseases [26].”
From A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial (2010) · cites this paper as [26]
Citations
Cites
The two‐period cross‐over clinical trial.
Hills, M., & Armitage, P. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb05903.x · Cited by 1,395
The Two-Period Change-Over Design and Its Use in Clinical Trials
Grizzle, J. E. (1965) · Biometrics · doi:10.2307/2528104 · Cited by 784
Within-subjects designs: To use or not to use?
Greenwald, A. G. (1976) · Psychological Bulletin · doi:10.1037/0033-2909.83.2.314 · Cited by 523
The Crossover Experiment for Clinical Trials
Brown, B. W. (1980) · Biometrics · doi:10.2307/2530496 · Cited by 372
Learned Taste Aversions in Children Receiving Chemotherapy
Bernstein, I. L. (1978) · Science · doi:10.1126/science.663613 · Cited by 305
Current trends and issues in adaptation-level theory.
Helson, H. (1964) · American Psychologist · doi:10.1037/h0040013 · Cited by 246
Pretreatment Nausea in Cancer Chemotherapy: A Conditioned Response?*
Nesse, R. M., Carli, T., Curtis, G. C., & Kleinman, P. D. (1980) · Psychosomatic Medicine · doi:10.1097/00006842-198001000-00004 · Cited by 159
Switchback Trials for More than Two Treatments
Lucas, H. L. (1956) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(56)94721-x · Cited by 146
Stimulus intensity effects depend upon the type of experimental design.
Grice, R. G., & Hunter, J. J. (1964) · Psychological Review · doi:10.1037/h0047547 · Cited by 141
Two-Treatment Crossover Designs for Estimating a Variety of Effects
Kershner, R. P., & Fédérer, W. T. (1981) · Journal of the American Statistical Association · doi:10.1080/01621459.1981.10477693 · Cited by 124
Research works printed but not linked: 8
- O'Neill R, 1977, Report of the Food and Drug Administration's Biometric and Epidemiological Methodology Advisory Committee
- Fleiss J . The Design and Analysis of Clinical Experiments. New York: John Wiley & Sons; 1986:263-90.
- Cochran W and Cox G . Experimental Designs. 2nd ed. New York: John Wiley & Sons; 1957:127-43.
- Winer B . Statistical Principles in Experimental Design. New York: McGraw-Hill; 1971:685-751.
- Williams E, 1949, Aust J Sci Res Series A., 2, 149
- Corso J . The Experimental Psychology of Sensory Behavior. New York: Holt, Rinehart & Winston; 1967:508-49.
- Olver I, 1986, Cancer Treat Rep., 70, 555
- Chassan J, 1970, J Clin Pharmacol., 10, 359
Cited by
Design of Treatment Trials for Functional Gastrointestinal Disorders
Irvine, E. J., Tack, J., Crowell, M. D., Gwee, K. A., Ke, M., Schmulson, M. J., Whitehead, W. E., & Spiegel, B. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.010 · Cited by 550
Cooper, D. J., Walley, K. R., Wiggs, B. R., & Russell, J. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-7-492 · Cited by 452
Therapeutic Massage and Healing Touch Improve Symptoms in Cancer
Post-White, J., Kinney, M. E., Savik, K., Gau, J. B., Wilcox, C., & Lerner, I. (2003) · Integrative Cancer Therapies · doi:10.1177/1534735403259064 · Cited by 300
Cicerone, K., Levin, H., Malec, J., Stuss, D., & Whyte, J. (2006) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2006.18.7.1212 · Cited by 288
Strumpf, D. A., Millman, R. P., Carlisle, C. C., Grattan, L. M., Ryan, S. M., Erickson, A. D., & Hill, N. S. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.6.1234 · Cited by 272
Metadata
- Authors
- Woods, J. R., Williams, J. G., & Tavel, M.
- Affiliations
- Methodist Hospital (US)
- Corresponding author
- Woods, John R.
- ORCID
- Tavel, Morton
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1989-04-01
- Volume
- 110
- Issue
- 7
- Pages
- 560-566
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2136646847
- Cited by
- 139
- References
- 17
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 5 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 2 · 2012: 3
- FWCI
- 14.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Management Science and Operations Research › Optimal Experimental Design Methods
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
- Keywords
- crossover design, residual effects, treatment effect estimation, order effects, parallel design, clinical trials
- MeSH terms
- Clinical Trials as Topic, Data Interpretation, Statistical, Humans, Research Design, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Two-Period Crossover Design in Medical Research. https://app.cochat.ai/papers/10.7326/0003-4819-110-7-560
- The paper
- Woods, J. R., Williams, J. G., & Tavel, M. (1989). The Two-Period Crossover Design in Medical Research. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-110-7-560
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.